无锡帕母医疗技术有限公司
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval 2024-01-02 20:30
TCT2022| Pulnovo Medical Announced That The Latest Results Of PADN-CFDA Pivotal Trial Indicate Effectiveness And Safety of PADN For The Treatment Of Pulmonary Arterial Hypertension (PAH) 2022-09-23 20:30
Pulnovo Medical Concludes Successfully the First Steering Committee Meeting 2022-09-08 20:30
Pulnovo Medical Appoints Ms. Jessie Lian Jia as New CEO 2022-03-10 20:00
1